Yale New Haven Hospital today announced that Thomas Balcezak, MD, MPH has been appointed Chief Medical Officer, effective immediately. Dr. Balcezak was formerly Senior Vice President and Chief Quality Officer for Yale New Haven Hospital, with responsibility for clinical quality, operations improvement, physician credentialing, hospital licensure and accreditation, and program development in the Neurosciences and Medicine Service Lines.
“Dr. Balcezak is eminently qualified for the role of Chief Medical Officer,” said Richard D’Aquila, President of Yale New Haven Hospital and Executive Vice President of Yale New Haven Health System. “He has spent the last 15 years in leadership positions at Yale New Haven Hospital, progressively increasing his responsibilities for performance management, clinical oversight, and medical affairs management.”
As the Chief Medical Officer, Dr. Balcezak will be responsible for all aspects of medical staff affairs administration, graduate medical education, patient safety and clinical quality, accreditation and regulatory readiness, the Hospitalist service, and care management. He will also continue to lead Yale New Haven Health System’s clinical redesign efforts.
A board-certified internist, Dr. Balcezak earned his medical degree from the University of Connecticut and Master’s degree in Public Health from Yale University. He completed his internship and residency training in Internal Medicine at Yale New Haven Hospital, where he also served as Chief Medical Resident. He is an Associate Clinical Professor of Medicine and lecturer in Public Health at the Yale University School of Medicine, Fellow in the American College of Healthcare Executives and American Board of Internal Medicine.
Natives to Connecticut, Dr. Balcezak and his wife Dr. Soni Clubb live in New Haven with their two daughters.
9/5/2024
Smilow announces first administration of unprecedented radiotherapy treatmentNew Haven, CT (Sept. 5, 2024) – Smilow Cancer Hospital at Yale New Haven today announced they successfully delivered the world’s first radiotherapy treatment plan that efficiently combines different radiotherapy modalities to treat a patient with metastatic cancer.
7/16/2024
Smilow Cancer Hospital at Waterford earns accreditation with commendationWaterford, CT (July 16, 2024) – The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACoS), has granted a new three-year accreditation with commendation to the cancer program at Smilow Cancer Hospital at Waterford.
7/16/2024
Yale New Haven Hospital nationally ranked in 11 specialties by U.S. News & World ReportNEW HAVEN, CT (July 16, 2024) – Yale New Haven Hospital (YNHH) continues to rank among the top hospitals in the country according to U.S. News & World Report’s annual “America’s Best Hospitals” listing.